• 1
    Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-1599.
  • 2
    Vasseur F, Helbecque N, Lobbens S, et al. Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: Evidence for a role of ACDC in diabesity. Diabetologia 2005;48:892-899.
  • 3
    Hivert MF, Manning AK, McAteer JB, et al. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: The Framingham Offspring Study. Diabetes 2008;57:3353-3359.
  • 4
    Comuzzie AG, Funahashi T, Sonnenberg G, et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 2001;86:4321-4325.
  • 5
    Lindsay RS, Funahashi T, Krakoff J, et al. Genome-wide linkage analysis of serum adiponectin in the Pima Indian population. Diabetes 2003;52:2419-2425.
  • 6
    Chuang LM, Chiu YF, Sheu WH, et al. Biethnic comparisons of autosomal genomic scan for loci linked to plasma adiponectin in populations of Chinese and Japanese origin. J Clin Endocrinol Metab 2004;89:5772-5778.
  • 7
    Heid IM, Henneman P, Hicks A, et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: Results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010;208:412-420.
  • 8
    Ling H, Waterworth DM, Stirnadel HA, et al. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS study. Obesity (Silver Spring) 2009;17:737-744.
  • 9
    Dastani Z, Hivert MF, Timpson N, et al. Novel Loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 2012;8:e1002607.
  • 10
    Vionnet N, Hani EH, Dupont S, et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000;67:1470-1480.
  • 11
    Kissebah AH, Sonnenberg GE, Myklebust J, et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci USA 2000;97:14478-14483.
  • 12
    Henkin L, Bergman RN, Bowden DW, et al. Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann Epidemiol 2003;13:211-217.
  • 13
    Steil GM, Volund A, Kahn SE, et al. Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes 1993;42:250-256.
  • 14
    Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 1985;6:45-86.
  • 15
    Wagenknecht LE, Mayer EJ, Rewers M, et al. The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. Ann Epidemiol 1995;5:464-472.
  • 16
    Wagenknecht LE, Bowden DW, Carr JJ, et al. Familial aggregation of coronary artery calcium in families with type 2 diabetes. Diabetes 2001;50:861-866.
  • 17
    Freedman BI, Hsu FC, Langefeld CD, et al. The impact of ethnicity and sex on subclinical cardiovascular disease: the Diabetes Heart Study. Diabetologia 2005;48:2511-2518.
  • 18
    Divers J, Wagenknecht LE, Bowden DW, et al. Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: the African American-diabetes heart study. Diabetes Care 2010;33:131-138.
  • 19
    McDonough CW, Palmer ND, Hicks PJ, et al. A genome-wide association study for diabetic nephropathy genes in African Americans. Kidney Int 2011;79:563-572.
  • 20
    Bowden DW, An SS, Palmer ND, et al. Molecular basis of a linkage peak: exome sequencing and family-based analysis identify a rare genetic variant in the ADIPOQ gene in the IRAS Family Study. Hum Mol Genet 2010;19:4112-4120.
  • 21
    Kita A, Yamasaki H, Kuwahara H, et al. Identification of the promoter region required for human adiponectin gene transcription: association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha. Biochem Biophys Res Commun 2005;331:484-490.
  • 22
    Heid IM, Henneman P, Hicks A, et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 208:412-420.
  • 23
    Waki H, Yamauchi T, Kamon J, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003;278:40352-40363.
  • 24
    Guo X, Saad MF, Langefeld CD, et al. Genome-wide linkage of plasma adiponectin reveals a major locus on chromosome 3q distinct from the adiponectin structural gene: the IRAS family study. Diabetes 2006;55:1723-1730.
  • 25
    O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998;63:259-266.
  • 26
    Almasy L, Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:1198-1211.
  • 27
    Tang H, Peng J, Wang P, et al. Estimation of individual admixture: analytical and study design considerations. Genet Epidemiol 2005;28:289-301.
  • 28
    Gauderman WJ. Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 2002;21:35-50.
  • 29
    Gao H, Fall T, van Dam RM, et al. Evidence of a causal relationship between adiponectin levels and insulin sensitivity: a mendelian randomization study. Diabetes 2012. Epub ahead of print.
  • 30
    National Diabetes Fact Sheet. 2011. national estimates and general information on diabetes and prediabetes in the United States. Available at: (2011) Accessed October 25 2011.
  • 31
    Wang Y, Lam KS, Chan L, et al. Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex. J Biol Chem 2006;281:16391-16400.
  • 32
    Han LY, Wu QH, Jiao ML, et al. Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 2011;54:2303-2314.
  • 33
    Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-2229.
  • 34
    Olckers A, Towers GW, van der Merwe A, et al. Protective effect against type 2 diabetes mellitus identified within the ACDC gene in a black South African diabetic cohort. Metabolism 2007;56:587-592.
  • 35
    Schwarz PE, Govindarajalu S, Towers W, et al. Haplotypes in the promoter region of the ADIPOQ gene are associated with increased diabetes risk in a German Caucasian population. Horm Metab Res 2006;38:447-451.
  • 36
    Laumen H, Saningong AD, Heid IM, et al. Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes 2009;58:984-991.
  • 37
    Warren LL, Li L, Nelson MR, et al. Deep resequencing unveils genetic architecture of ADIPOQ and identifies a novel low-frequency variant strongly associated with adiponectin variation. Diabetes 2012;61:1297-1301.
  • 38
    An SS, Palmer ND, Hanley AJ, et al. Estimating the contributions of rare and common genetic variations and clinical measures to a model trait: adiponectin. Genetic Epidemiology ;37:13-24.
  • 39
    Hanley AJ, Wagenknecht LE, Norris JM, et al. Adiponectin and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family Study. Diabetes Care 2011;34:2231-2236.
  • 40
    Zhu N, Pankow JS, Ballantyne CM, et al. High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study. J Clin Endocrinol Metab 2010;95:5097-5104.